Immediate Impact

51 standout
Sub-graph 1 of 24

Citing Papers

Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
2024 Standout
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
7 intermediate papers

Works of Arcot Rekha being referenced

A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]
2005

Author Peers

Author Last Decade Papers Cites
Arcot Rekha 82 23 28 76 62 45 303
Sasima Tongsai 130 35 36 56 76 39 361
Jin Suk Kang 41 10 28 48 43 33 253
Yoann Zerbib 33 71 24 35 45 31 296
Aikaterini Gkoufa 33 44 60 77 138 52 353
Konstantina Gartzonika 43 43 16 56 94 28 336
Mustafa Doğan 66 9 13 41 26 51 301
Chih-Hsiung Lee 99 38 11 37 24 36 364
Wei‐Ting Lin 61 41 3 24 91 39 273
Nathalie Layios 27 75 21 60 19 24 350
Clara Vigneron 22 42 35 27 42 49 323

All Works

Loading papers...

Rankless by CCL
2026